This indicates a synergistic effect between c-Abl activity and disease pathology in PD and suggesting a role for c-Abl in the brain's inability to dispose of toxic proteins in proteinopathies such as AD and PD. This evidence concerns the gene ABL1 and proteostasis deficiencies.